Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-11-097355
Filing Date
2011-11-10
Accepted
2011-11-10 11:06:43
Documents
13
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q y92980e10vq.htm 10-Q 457193
2 EX-31.A y92980exv31wa.htm EX-31.A 5650
3 EX-31.B y92980exv31wb.htm EX-31.B 5690
4 EX-32.A y92980exv32wa.htm EX-32.A 3068
5 EX-32.B y92980exv32wb.htm EX-32.B 3092
6 EX-99.1 y92980exv99w1.htm EX-99.1 85978
13 GRAPHIC y92980y9298000.gif GRAPHIC 8476
  Complete submission text file 0000950123-11-097355.txt   2085714

Data Files

Seq Description Document Type Size
7 EX-101 INSTANCE DOCUMENT dusa-20110930.xml EX-101.INS 291730
8 EX-101 SCHEMA DOCUMENT dusa-20110930.xsd EX-101.SCH 12929
9 EX-101 CALCULATION LINKBASE DOCUMENT dusa-20110930_cal.xml EX-101.CAL 30863
10 EX-101 LABELS LINKBASE DOCUMENT dusa-20110930_lab.xml EX-101.LAB 113201
11 EX-101 PRESENTATION LINKBASE DOCUMENT dusa-20110930_pre.xml EX-101.PRE 69900
12 EX-101 DEFINITION LINKBASE DOCUMENT dusa-20110930_def.xml EX-101.DEF 9699
Mailing Address 25 UPTON DRIVE WILMINGTON MA 01887
Business Address 25 UPTON DRIVE WILMINGTON MA 01887 9786577500
DUSA PHARMACEUTICALS INC (Filer) CIK: 0000879993 (see all company filings)

EIN.: 223103129 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31533 | Film No.: 111193792
SIC: 2834 Pharmaceutical Preparations